cancer of the ovary Ovarian cancer
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: • Patients with recurrent EOC or tubal carcinoma or peritoneal carcinoma; • Histologically and/or cytologically proven epithelial ovarian cancer (including carcinosarcoma of the ovaries) • Measurable or evaluable disease confirmed by radiological imaging OR ca 125 • ECOG =12 weeks • Patients must be accessible for treatment and follow-up • Fit to receive chemotherapy
Exclusion criteria
Exclusion criteria: • Patients with benign ovarian cancer; • Patients with non-epithelial cancer; • Bowel obstruction, sub-occlusive disease or presence of symptomatic brain metastases; • Patients with other malignancy occurring within 5 years before enrollment • Patients with impaired cognitive functioning or analphabetic patients • Patients with an inability to fill in surveys digitally
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| the velocity of disease symptom relief and its duration by systemic therapy measured by questionnaires on PROs and response to therapy. Primary endpoints: changes in outcomes on QoL and symptoms due to disease and treatment. | — |
Secondary
| Measure | Time frame |
|---|---|
| Petient reported disease symptoms top 3, response to therapy as measured by CA-125 and radiology, distress, emotional wellbeing, Empowerment and change in patient reported needs. | — |
Countries
Netherlands